We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+4.61%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$3.85B
AUM Growth
+$230M
Cap. Flow
+$85.4M
Cap. Flow %
2.22%
Top 10 Hldgs %
13.56%
Holding
1,766
New
85
Increased
690
Reduced
800
Closed
84

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$14.2M
2
BHI
Baker Hughes
BHI
+$12.3M
3
MCHP icon
Microchip Technology
MCHP
+$7.9M
4
MAT icon
Mattel
MAT
+$7.07M
5
BA icon
Boeing
BA
+$6.9M

Sector Composition

Rank Sector Weight
1 Financials 15.43%
2 Technology 14.53%
3 Healthcare 14.49%
4 Industrials 12.48%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSTR icon
1001
Landstar System
LSTR
$6.01B
$240K 0.01%
2,409
-18
-0.7% -$1.6K
GAP
1002
The Gap Inc
GAP
$7.39B
$240K 0.01%
+8,126
New +$200K
LOGM
1003
DELISTED
LogMein, Inc.
LOGM
$239K 0.01%
2,176
+66
+3% +$7.4K
KYNB
1004
Kyntra Bio
KYNB
$28.3M
$237K 0.01%
176
+93
+112% +$98K
VAC icon
1005
Marriott Vacations Worldwide
VAC
$4.28B
$237K 0.01%
1,902
-13
-0.7% -$1.5K
LMAT icon
1006
LeMaitre Vascular
LMAT
$1.85B
$236K 0.01%
6,313
-42
-0.7% -$1.43K
CNMD icon
1007
CONMED
CNMD
$1.49B
$235K 0.01%
4,486
-1
-0% -$50
IBDR icon
1008
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.39B
$235K 0.01%
+9,532
New +$235K
SPIB icon
1009
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$231K 0.01%
6,708
-216
-3% -$7.46K
LDOS icon
1010
Leidos
LDOS
$17B
$230K 0.01%
3,883
+772
+25% +$43K
M icon
1011
Macy's
M
$6.61B
$230K 0.01%
+10,561
New +$232K
INVX
1012
Innovex International
INVX
$2.15B
$230K 0.01%
5,201
+89
+2% +$3.87K
KSS icon
1013
Kohl's
KSS
$2.09B
$229K 0.01%
5,026
-5,105
-50% -$209K
ATI icon
1014
ATI
ATI
$30.5B
$228K 0.01%
9,533
-54
-0.6% -$1.07K
EG icon
1015
Everest Group
EG
$14.2B
$228K 0.01%
+1,000
New +$252K
COL
1016
DELISTED
Rockwell Collins
COL
$228K 0.01%
1,750
-86
-5% -$10.4K
BEAT
1017
DELISTED
BioTelemetry, Inc.
BEAT
$226K 0.01%
6,843
-327
-5% -$11.3K
BRFS
1018
DELISTED
BRF SA
BRFS
$225K 0.01%
15,618
+3,809
+32% +$49.6K
RLJ icon
1019
RLJ Lodging Trust
RLJ
$1.81B
$225K 0.01%
+10,228
New +$211K
DB icon
1020
Deutsche Bank
DB
$70.7B
$224K 0.01%
12,984
LH icon
1021
Labcorp
LH
$25.7B
$224K 0.01%
1,727
-102
-6% -$13.6K
UMPQ
1022
DELISTED
Umpqua Holdings Corp
UMPQ
$224K 0.01%
11,455
-60
-0.5% -$1.09K
HDS
1023
DELISTED
HD Supply Holdings, Inc.
HDS
$223K 0.01%
6,179
-11,779
-66% -$379K
ABCO
1024
DELISTED
Advisory Board Co
ABCO
$223K 0.01%
4,153
-940
-18% -$50.6K
TRUP icon
1025
Trupanion
TRUP
$1.24B
$221K 0.01%
+8,372
New +$192K

Similar funds

Oppenheimer Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Oppenheimer Asset Management held 1,766 positions worth $3.85B, up 6.4% from $3.62B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer Asset Management's Q3 2017 filing shows 85 new, 690 increased, 800 reduced and 84 closed positions. Its largest new stake was Baker Hughes: 313,683 shares worth $11.5M. The largest sale was Du Pont De Nemours E I, an estimated $14.2M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • Oppenheimer Asset Management's largest Q3 2017 buy was Baker Hughes: 313,683 shares worth $11.5M.
  • Oppenheimer Asset Management added most to Advance Auto Parts in Q3 2017, an estimated $36.4M increase.
  • Oppenheimer Asset Management's biggest Q3 2017 reduction was Microchip Technology, cutting an estimated $7.9M.
  • Oppenheimer Asset Management fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $14.2M.
  • Oppenheimer Asset Management's ten largest holdings make up 14% of its $3.85B portfolio in Q3 2017.
  • Oppenheimer Asset Management opened 85 new positions and closed 84 in Q3 2017.
  • Oppenheimer Asset Management's portfolio value rose 6.4% quarter-over-quarter to $3.85B.

Based on Oppenheimer Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.